Merck & Co., Inc. (MRK)
Merck's stock is nearing a 52-week high, boosted by positive news like Keytruda's subcutaneous formulation approval and strong social media sentiment. However, concerns linger over UK investment cuts and vaccine safety.
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company.
Merck & Co., Inc. uses the ticker $MRK for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Merck & Co., Inc. (MRK) social dominance is up 1851.56% from the previous week.
- Merck & Co., Inc. (MRK) posts created is up 105.5% from the previous month.
- Merck & Co., Inc. Price hit a 52-Week high of $122.60 for the hour
Price: $121.90
Price 24-Hour Time-Series Raw Data
Merck's stock price is near a 52-week high, supported by positive developments like Keytruda's subcutaneous formulation approval and strong social media sentiment. Analyst upgrades also contribute to this upward momentum.
24-Hour: 0.39% 7-Day: 3.78% 30-Day: 12%
1-Year High: $121.90 on 2026-02-06
1-Year Low: $73.50 on 2025-05-14
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Merck & Co., Inc. (MRK) is currently AltRank #178 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +38
[--] Month: [---] [---]
[--] Months: [---] [---]
[--] Year: [---] +103
1-Year High: [-----] on 2025-03-16
1-Year Low: [--] on 2025-04-21
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-07
1-Year Low: [--] on 2025-08-06
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] -66%
[--] Month: [----------] +37%
[--] Months: [----------] +13%
[--] Year: [-----------] -12%
1-Year High: [---------] on 2025-02-22
1-Year Low: [------] on 2025-03-01
Engagements by network (24h): YouTube: [------] X: [------] News: [---] Reddit: [-----] TikTok: [------] Instagram: [---]
Mentions: [-----] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -10%
[--] Month: [------] +90%
[--] Months: [------] +38%
[--] Year: [-------] +130%
1-Year High: [-----] on 2025-07-03
1-Year Low: [---] on 2025-12-07
Mentions by network (24h): YouTube: [---] X: [---] News: [--] Reddit: [--] TikTok: [---] Instagram: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Merck & Co., Inc. (MRK) in the last [--] hours which is down 2.80% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [-----] -13%
[--] Month: [-----] +55%
[--] Months: [------] +31%
[--] Year: [------] +312%
1-Year High: [-----] on 2025-07-03
1-Year Low: [---] on 2025-12-07
The most influential creators that mention Merck & Co., Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @christianmerckvideos | [--] | [-------] | [--] | [------] |
| @tunemusicalmoments | [--] | [---------] | [--] | [-----] |
| @POTUS47Achieve | [--] | [---] | [--] | [-----] |
| @bioinvestor24 | [--] | [-----] | [--] | [-----] |
| @adrmrck13 | [--] | [-----] | [--] | [-----] |
| @wallstlobo | [--] | [---] | [--] | [-----] |
| @christiangrey1125 | [--] | [---------] | [--] | [-----] |
| @doepke_michel | [--] | [-----] | [--] | [-----] |
| @Tickerwire | [--] | [-----] | [--] | [-----] |
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
Sentiment: 83%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 83%
Daily Average: 74%
[--] Week: 62% -10%
[--] Month: 80% +6%
[--] Months: 80% -2%
[--] Year: 80% +39%
1-Year High: 94% on 2025-02-22
1-Year Low: 41% on 2025-03-30
Most Supportive Themes:
- Keytruda Approval and Subcutaneous Formulation: (25%) Positive sentiment surrounding the FDA approval of Keytruda's new subcutaneous formulation, offering more convenient administration.
- Merck Foundation Initiatives: (15%) Appreciation for Merck Foundation's programs focused on healthcare capacity, girl education, and women's empowerment.
Most Critical Themes:
- UK Investment Cuts: (30%) Concerns over Merck's decision to scrap a UK research facility and reduce investments due to unfavorable policies.
- Vaccine Safety Concerns: (20%) Criticism and skepticism regarding vaccine safety, particularly the HPV vaccine Gardasil, and alleged suppression of data.
Social Dominance: 0.084%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.084%
Daily Average: 0.204%
[--] Week: 2% +1.90%
[--] Month: 0.127% -0.046%
[--] Months: 0.127% -0.186%
[--] Year: 0.127% -0.102%
1-Year High: 0.538% on 2025-07-07
1-Year Low: 0.094% on 2025-12-07
Market Dominance: 0.342%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.342%
Daily Average: 7%
1-Year High: 14% on 2026-02-06
1-Year Low: 0.281% on 2025-05-08
Market Cap: $302,508,906,688
Market Cap 24-Hour Time-Series Raw Data
Current Value: $302,508,906,688
Daily Average: $224,669,164,751
[--] Week: $301,379,586,434 +3.40%
[--] Month: $301,379,586,434 +12%
[--] Months: $301,379,586,434 +40%
[--] Year: $301,379,586,434 +20%
1-Year High: $302,633,007,814 on 2026-02-06
1-Year Low: $184,485,466,158 on 2025-05-14
Top Merck & Co., Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Buy Walmart Seller Accounts $PYPL $MRK $PFE $PEP $FUBO $ETN $GLXY $ADM $MPC $TDG $AMD $SMCI $CMG $ENPH $AMGN $LITE $TTWO $MDLZ $AMCR $CB $DIS $IDXX $TSN $APTV $RVTY $TWST $HESM $NSSC $ARLP $PLTR $TER $NXPI $FN $RMBS $DOC $WWD $SPG $DVA $TWO https://seovcc.com/product/buy-walmart-seller-accounts/ https://seovcc.com/product/buy-walmart-seller-accounts/"
X Link @hopkinsdax39399 2026-02-17T14:18Z [---] followers, [---] engagements
"The word out ( from Pharma chatters ) there is more than one big pharma looking for late stage GLP1 GIP dual agonist and all are concerned if anyone can ever outbid $NVO ( that may go all in ) $BMY $MRK $ABBV $LLY $JNJ"
X Link @bioinvestor24 2026-02-17T13:52Z [----] followers, [----] engagements
"Healthcare $XLV - YTD: 1.85% Eli Lilly and Company $LLY - YTD: -3.07% Johnson & Johnson $JNJ - YTD: 17.64% AbbVie Inc. $ABBV - YTD: 1.32% Merck & Co. Inc. $MRK - YTD: 15.34% UnitedHealth Group Inc $UNH - YTD: -11.18% https://twitter.com/i/web/status/2023734771139150043 https://twitter.com/i/web/status/2023734771139150043"
X Link @WallStDiaries 2026-02-17T12:22Z 26.6K followers, [---] engagements
"Citizens🏁 $IMMP and said We are initiating coverage of Immutep Limited with a Market Outperform rating and $6 price target based on a revenue and earnings multiple analysis. $MRK AUTL ALLO ANL SMMT DSNKY AZN BMY $NUVL Citizens added Eftilagimod alpha ('efti') has demonstrated strong clinical immunostimulatory effects that potentiate and expand the effectiveness of established checkpoint inhibitor (CPI) therapies across multiple large Phase [--] studies. The company is currently conducting a large randomized Phase [--] study evaluating the combination of efti + pembro/chemo versus pembro/chemo"
X Link @Quantumup1 2026-02-17T12:04Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing